Nanotechnology-based drug delivery for the treatment of CNS disorders

Approximately 6.8 million people die annually because of problems related to the central nervous system (CNS), and out of them, approximately 1 million people are affected by neurodegenerative diseases that include Alzheimer’s disease, multiple sclerosis, epilepsy, and Parkinson’s disease. CNS probl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mittal, Khushi R., Pharasi, Nandini, Sarna, Bhavya, Singh, Manisha, Rachana, Haider, Shazia, Singh, Sachin Kumar, Dua, Kamal, Jha, Saurabh Kumar, Dey, Abhijit, Ojha, Shreesh, Mani, Shalini, Jha, Niraj Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883694/
https://www.ncbi.nlm.nih.gov/pubmed/36741545
http://dx.doi.org/10.1515/tnsci-2022-0258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883694/
https://www.ncbi.nlm.nih.gov/pubmed/36741545
http://dx.doi.org/10.1515/tnsci-2022-0258

Ejemplares similares